Cargando…
Discovery of a highly potent glucocorticoid for asthma treatment
Glucocorticoids are the most effective treatment for asthma. However, their clinical applications are limited by low efficacy in severe asthma and by undesired side effects associated with high dose or prolonged use. The most successful approach to overcome these limitations has been the development...
Autores principales: | He, Yuanzheng, Shi, Jingjing, Yi, Wei, Ren, Xin, Gao, Xiang, Li, Jianshuang, Wu, Nanyan, Weaver, Kevin, Xie, Qian, Khoo, Sok Kean, Yang, Tao, Huang, Xiaozhu, Melcher, Karsten, Xu, H Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822341/ https://www.ncbi.nlm.nih.gov/pubmed/27066265 http://dx.doi.org/10.1038/celldisc.2015.35 |
Ejemplares similares
-
The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds
por: Sasi, Nanda Kumar, et al.
Publicado: (2014) -
Clinical and molecular aspects of glucocorticoid resistant asthma
por: Corrigan, Chris J, et al.
Publicado: (2007) -
Genomic and non-genomic actions of glucocorticoids in asthma
por: Alangari, Abdullah A.
Publicado: (2010) -
Is there a role for glucocorticoid receptor beta in asthma?
por: Gagliardo, Rosalia, et al.
Publicado: (2001) -
Heterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma
por: Matsumura, Yasuhiro
Publicado: (2010)